Skip to content
Research/Bioregulators/Vesugen

Vesugen

Synthetic tripeptide vascular bioregulator. Promotes endothelial cell renewal, improves vascular function, supports cardiovascular health. Sequence: Lys-Glu-Asp.

Intelligence Profile

Science

Mechanism of Action

Based on the available evidence, Vesugen appears to be a short peptide compound, though the specific molecular mechanisms are not well-characterized in the provided research. The evidence suggests several potential pathways of action:

Cellular Protection and Anti-Aging Effects
The most recent research (2024) indicates that Vesugen and related short peptides may protect neurons from age-related changes, specifically in fibroblast-derived induced neurons. However, the exact molecular mechanisms underlying this protective effect are not detailed in the available evidence.

Gene Expression Modulation
Studies from 2020 suggest that short peptides like Vesugen can modulate gene expression in aging human mesenchymal stem cell cultures. This indicates the compound may work at the transcriptional level, though the specific genes targeted and pathways involved are not specified in the available abstracts.

Neurogenesis and Stem Cell Differentiation
Research from 2019 and 2021 suggests involvement in neuronal differentiation of stem cells and neurogenesis regulation, particularly in the context of Alzheimer's disease. One study specifically mentions "Peptide KED" in relation to molecular-genetic aspects of neurogenesis regulation, though whether this refers to Vesugen or a related compound is unclear from the evidence provided.

Vascular and Tissue Effects
Earlier research (2016) indicates potential vasoprotective activity during atherosclerosis and effects on skin fibroblast functions during cellular aging, suggesting broader tissue-protective mechanisms.

Evidence Limitations
The available evidence provides limited detail about Vesugen's specific molecular mechanisms. Most studies focus on biological effects rather than detailed mechanistic pathways. Additionally, some research appears to involve related peptides that may or may not be identical to Vesugen, making it difficult to draw definitive conclusions about this specific compound's mechanism of action.

More detailed mechanistic studies would be needed to fully characterize how Vesugen works at the molecular and physiological level.